학술논문
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma
Document Type
Journal
Author
Martinez-Cibrian, Nuria; Ortiz-Maldonado, Valentin; Espanol-Rego, Marta; Blazquez, Andrea; Cid, Joan; Lozano, Miquel; Magnano, Laura; Gine, Eva; Correa, Juan G.; Mozas, Pablo; Rodriguez-Lobato, Luis Gerardo; Rivero, Andrea; Montoro-Lorite, Mercedes; Ayora, Pilar; Navarro, Sergio; Alserawan, Leticia; Gonzalez-Navarro, E. Azucena; Castella, Maria; Sanchez-Castanon, Maria; Cabezon, Raquel; Benitez-Ribas, Daniel; Setoain, Xavier; Rodriguez, Sonia; Brillembourg, Helena; Varea, Sara; Olesti, Eulalia; Guillen, Elena; Saez-Penataro, Joaquin; de Larrea, Carlos Fernandez; Lopez-Guillermo, Armando; Pascal, Mariona; Urbano-Ispizua, Alvaro; Juan, Manel; Delgado, Julio
Source
Subject
Language
English
ISSN
13652141